SEC Filings

Filing date Description Form View

REGDEX

 REGDEX View HTML

REGDEX

 REGDEX View HTML
D View HTML
0001341235-13-000002.pdf

Registration statement for face-amount certificate companies

 S-1 View HTML
0001193125-14-002908.pdf
0001193125-14-002908.xls

Amended Registration statement for face-amount certificate companies

 S-1/A View HTML
0001193125-14-022166.pdf
0001193125-14-022166.xls

Registration of certain classes of securities 12(b) of the Securities Exchange Act

 8-A12B View HTML
0001193125-14-082131.pdf
0001193125-14-082131.xls

Amended Registration statement for face-amount certificate companies

 S-1/A View HTML
0001193125-14-102690.pdf
0001193125-14-102690.xls

Amended Registration statement for face-amount certificate companies

 S-1/A View HTML
0001193125-14-109806.pdf
0001193125-14-109806.xls

FWP

 FWP View HTML
0001193125-14-110002.pdf
0001193125-14-110002.xls

Amendment to a previously filed 8-A12B

 8-A12B/A View HTML
0001193125-14-112140.pdf
0001193125-14-112140.xls

Copyright Morningstar

Safe Harbor Disclosure

This video content contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding Aldeyra’s possible or assumed future results of operations, expenses and financing needs, business strategies and plans, research and development plans or expectations, trends, the structure, timing and success of Aldeyra’s planned or pending clinical trials, expected milestones, market sizing, pricing and reimbursement, competitive position, regulatory matters, industry environment and potential growth opportunities, among other things. Actual results or trends could differ materially from those contemplated by these forward-looking statements. For more information, please refer to the risk factors discussed in Aldeyra's periodic filings with the SEC, including the most recent Form 10-Q or 10-K. Any forward-looking statements that are made in the video content are based on assumptions as of the original date of the creation of such video, and Aldeyra undertakes no obligation to update these statements as a result of new information or future events.

Continue to video